PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2006

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/06/2006
Quarter2
Financial Year End31/12/2006
The figureshave not been audited

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2006


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/06/2006 
30/06/2005 
30/06/2006 
30/06/2005 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
251,133
242,784
501,887
470,656
2Profit/(loss) before tax
8,266
14,312
17,177
32,561
3Profit/(loss) for the period
6,084
9,074
12,000
21,091
4Profit/(loss) attributable to ordinary equity holders of the parent
5,663
8,711
11,122
19,410
5Basic earnings/(loss) per share (sen)
5.29
8.51
10.40
19.00
6Proposed/Declared dividend per share (sen)
11.50
10.50
11.50
10.50



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)

2.9600
2.9700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
No interim ordinary dividend has been declared for the financial period ended 30 June 2006 (2005:nil).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced16 Aug 2006  
CategoryFinancial Results
Reference NoPB-060801-61915